{"description":"Participants were given both dosages for varying lengths and the adverse events were not reported according to which timepoint neither at which dosage events occurred.","eventGroups":[{"description":"Bendamustine 90 or 120 mg/m\\^2 administered as an intravenous (IV) infusion over 60 minutes on Days 1 and 2 of each 21-day cycle (maximum of 12 total cycles), with delays up to 2 weeks for neutrophil and platelet count recovery, for up to a 35-day cycle.","id":"EG000","otherNumAffected":43,"otherNumAtRisk":43,"seriousNumAffected":33,"seriousNumAtRisk":43,"title":"Bendamustine"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":28,"numAtRisk":43,"numEvents":92}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":43,"numEvents":19}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":10}],"term":"Lymphopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43,"numEvents":8}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":5}],"term":"Pancytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":43,"numEvents":74}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":43,"numEvents":13}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":43,"numEvents":8}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":43,"numEvents":28}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Gingival bleeding"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":43,"numEvents":26}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":43,"numEvents":31}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Catheter site pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":4}],"term":"Chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Chills"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":43,"numEvents":10}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":4}],"term":"Mucosal inflammation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":10}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":43,"numEvents":35}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43,"numEvents":9}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43,"numEvents":11}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43,"numEvents":20}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":13}],"term":"Blood potassium decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":43,"numEvents":41}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":6}],"term":"Weight decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":43,"numEvents":12}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Fluid overload"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":14}],"term":"Hypercalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43,"numEvents":15}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":5}],"term":"Hyperkalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43,"numEvents":18}],"term":"Hypocalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":43,"numEvents":40}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":43,"numEvents":10}],"term":"Hypomagnesaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43,"numEvents":11}],"term":"Hyponatraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43,"numEvents":15}],"term":"Hypophosphataemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":4}],"term":"Tumour lysis syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":5}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":4}],"term":"Bone pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43,"numEvents":8}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":4}],"term":"Acute lymphocytic leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Acute myeloid leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":43,"numEvents":12}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":4}],"term":"Anxiety"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":43,"numEvents":13}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43,"numEvents":6}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":43,"numEvents":6}],"term":"Epistaxis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":4}],"term":"Productive cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":4}],"term":"Pulmonary oedema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Rhinorrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":4}],"term":"Dry skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":5}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":43,"numEvents":7}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":43,"numEvents":19}],"term":"Hypertension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":43,"numEvents":18}],"term":"Hypotension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":43,"numEvents":13}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Leukocytosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43,"numEvents":2}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43,"numEvents":2}],"term":"Pancytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43,"numEvents":2}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Cardiopulmonary failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Proctitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":2}],"term":"Multi-organ failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":7}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Portal vein thrombosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43,"numEvents":2}],"term":"Aspergillosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Beta haemolytic streptococcal infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Capnocytophagia infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":2}],"term":"Cellulitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Febrile infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Fungal sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43,"numEvents":3}],"term":"Herpes zoster"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Pharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Septic shock"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":2}],"term":"Staphylococcal infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Electrocardiogram QT prolonged"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Hypercalcaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Hyperkalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Tumour lysis syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":3}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":43,"numEvents":4}],"term":"Acute lymphocytic leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":43,"numEvents":3}],"term":"Acute myeloid leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"B precursor type acute leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43,"numEvents":4}],"term":"Leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Myeloid leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"T-cell type acute leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43,"numEvents":2}],"term":"Depressed level of consciousness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Confusional state"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Renal failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43,"numEvents":2}],"term":"Renal impairment"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":43,"numEvents":2}],"term":"Hypoxia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Respiratory distress"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Respiratory failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Hypotension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 13.0","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":43,"numEvents":1}],"term":"Peripheral artery aneurysm"}],"timeFrame":"Screening (Day -14 to Day-1) through end of treatment (up to 12 35-day cycles), plus 30 days."}